UnitedHealthcare · Nipt · US health-plan appeal rights

Nipt denied as experimental or investigational by UnitedHealthcare?

Q: How long do I have to appeal a UnitedHealthcare Nipt denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

An experimental denial requires the appeal to cite the FDA approval (if any), peer-reviewed phase III data, and the recognised specialty-society guideline that supports the treatment for your indication.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What UnitedHealthcare typically requires

UnitedHealthcare's specific coverage criteria for nipt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: UHC Commercial Medical Policy: NIPT (Cell-Free DNA Testing)

The UnitedHealthcare angle on Nipt

## Why UnitedHealthcare Denied NIPT as Experimental

An experimental or investigational denial means UHC determined that NIPT — or the specific clinical indication for which it was ordered — does not yet meet the plan's definition of proven, established medical practice. This framing is sometimes applied to expanded NIPT panels (microdeletion screens, genome-wide copy-number analysis) even when standard chromosomal NIPT is considered covered, or it may be applied to NIPT ordered outside the indications recognized in UHC's current coverage policy.

This type of denial is frequently overturned on appeal because NIPT for the most common aneuploidies has been endorsed by major professional societies (consult the current ACOG and SMFM guidance for the recognized indications) and is not investigational for those indications. If an expanded panel was ordered, the appeal should address whether that specific panel component was clinically necessary and supported by current guideline recommendations.

## Federal Appeal Framework

ACA §2719 external review: for fully insured non-grandfathered plans, you may request independent external review after exhausting internal appeals. The external review window is approximately four months from the final internal denial — verify the exact date on your denial letter.
ERISA §503: self-funded plans require internal exhaustion first; external review rights are plan-specific.
Expedited review: request this immediately if your gestational window makes standard timelines impractical.

## Appeal Process and Timeline

1. Obtain UHC's written clinical criteria for NIPT coverage and the specific experimental/investigational policy applied. 2. File a Level 1 internal appeal within the timeframe shown on your denial notice (typically 180 days from the EOB). 3. Escalate to external review after exhausting internal levels.

## Documentation to Gather

Clinical indication documentation: office notes and laboratory requisition confirming the clinical indication that prompted the NIPT order, cross-referenced to the indications recognized in current professional society guidance.
Ordering provider letter: a letter from the MFM specialist or obstetrician explaining why the specific NIPT panel ordered (standard or expanded) is medically necessary and consistent with current evidence-based practice, citing the relevant professional society guideline organization by name (not specific statistics).
Published guideline reference: a copy of the current relevant professional society (ACOG/SMFM) guideline or committee opinion recognizing the ordered test as an accepted clinical option for the patient's situation — without citing specific trial data.
Plan policy: a copy of the UHC medical policy applied and a clear, criterion-by-criterion response.

## Criteria-Mapping Structure

List each criterion from UHC's experimental/investigational policy verbatim. For each, write the specific chart-based or guideline-based rebuttal: if the policy requires peer-reviewed evidence of efficacy, cite the name of the professional society guideline (not a specific trial or statistic) that endorses the test for this indication. If the policy excludes expanded panels, address whether the specific component ordered has its own guideline endorsement.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other UnitedHealthcare appeals

Other denial reasons for UnitedHealthcare Nipt

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.